Patenting by European universities on the rise

High concentrations of academic patents at some universities and in some countries

23-Oct-2024 - European universities are behind more than 10% of all patent applications filed at the EPO from within Europe. However, wide variations in patterns of ownership and commercialisation are much in evidence. Europe’s universities are becoming increasingly vibrant workshops for many inventions in ...

Startups with patents and trade marks are 10 times more successful in securing funding

Biotechnology sector leads in the use of patents and trade marks, with nearly half of the sector’s startups seeking these essential rights

19-Oct-2023 - the European Patent Office (EPO) and the European Union Intellectual Property Office (EUIPO) have published a new joint study highlighting how much patents and trade marks can boost the success of European startups. The report shows that, on average, startups that possess these two types of ...

SYGNIS strengthens its KIBRA-Project: First Patents announced for Europe and the USA

09-May-2011 - SYGNIS Pharma AG announced that both the European Patent Office (EPO) and the US Patent and Trademark Office (USPTO) have given notice that they expect to issue elementary KIBRA-patent-applications.Dr. Frank Rathgeb, CMO of SYGNIS commented: “We are encouraged to receive the notification from the ...

KINAXO Announces European Patent Granted for its Chemical Proteomics Applications

13-Apr-2011 - KINAXO Biotechnologies GmbH announced that the European Patent Office has granted a patent entitled “Proteome-wide quantification of small molecule binding to cellular target proteins” (EP2045332B1). The patent covers technologies exclusively marketed by KINAXO under the trademarks Cellular ...

caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology

04-Mar-2011 - caprotec bioanalytics GmbH announced that the European Patent Office has granted the last of three core patents protecting its proprietary Capture Compound Mass Spectrometry (CCMS) technology. CCMS offers a novel and direct way to investigate small molecule - protein interactions resulting in a ...

MediGene: European Patent Office decides to grant new European Patent for Veregen

01-Dec-2008 - MediGene AG announced that the European Patent Office has decided to grant a further patent on Veregen® (Polyphenon E® Ointment). The patent covers the application of Veregen® in the treatment of skin and tumor diseases induced by papilloma viruses. Up to now, patent protection for Veregen® was ...